CoChat

Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature

Open access
Galamb, Orsolya, Györffy, Balázs, Sipos, Ferenc, Spisák, Sándor, Németh, Anna Mária, Miheller, Pál, Tulassay, Zsolt, Dinya, Elek, Molnár, Béla · 2008 · Disease Markers
Cited by 120

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Gene expression analysis of colon biopsies using high‐density oligonucleotide microarrays can contribute to the understanding of local pathophysiological alterations and to functional classification of adenoma (15 samples), colorectal carcinomas (CRC) (15) and inflammatory bowel diseases (IBD) (14). Total RNA was extracted, amplified and biotinylated from frozen colonic biopsies. Genome‐wide gene expression profile was evaluated by HGU133plus2 microarrays and verified by RT‐PCR. We applied two independent methods for data normalization and used PAM for feature selection. Leave one‐out stepwise discriminant analysis was performed. Top validated genes included collagenIVα1, lipocalin‐2, calumenin, aquaporin‐8 genes in CRC; CD44, met proto‐oncogene, chemokine ligand‐12, ADAM‐like decysin‐1 and ATP‐binding casette‐A8 genes in adenoma; and lipocalin‐2, ubiquitin D and IFITM2 genes in IBD. Best differentiating markers between Ulcerative colitis and Crohn′s disease were cyclin‐G2; tripartite motif‐containing‐31; TNFR shedding aminopeptidase regulator‐1 and AMICA. The discriminant analysis was able to classify the samples in overall 96.2% using 7 discriminatory genes (indoleamine‐pyrrole‐2,3‐dioxygenase, ectodermal‐neural cortex, TIMP3, fucosyltransferase‐8, collectin sub‐family member 12, carboxypeptidase D, and transglutaminase‐2). Using routine biopsy samples we successfully performed whole genomic microarray analysis to identify discriminative signatures. Our results provide further insight into the pathophysiological background of colonic diseases. The results set up data warehouse which can be mined further.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2008/586721

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 120

Metadata

Authors
Galamb, O., Györffy, B., Sipos, F., Spisák, S., Németh, A. M., Miheller, P., Tulassay, Z., Dinya, E., & Molnár, B.
Venue
Disease Markers
Publisher
Wiley
Published
2008-01
Volume
25
Issue
1
Pages
1-16
ISSN
  • 0278-0240 (ISSN-L)
  • 1875-8630
OpenAlex
W2113676124
Cited by
120
References
3
FWCI
2.85
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature. https://app.cochat.ai/papers/10.1155/2008/586721
The paper
Galamb, O., Györffy, B., Sipos, F., Spisák, S., Németh, A. M., Miheller, P., Tulassay, Z., Dinya, E., & Molnár, B. (2008). Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature. Disease Markers. https://doi.org/10.1155/2008/586721

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.